Nasdaq:CAPRPublished
Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy
Company receives Complete Response Letter from FDA for Deramiocel BLA Conference call and webcast Monday, November 23, at 8:30 a.m. ET SAN DIEGO, Nov.
